↓ Skip to main content

PLOS

Obesity, the Endocannabinoid System, and Bias Arising from Pharmaceutical Sponsorship

Overview of attention for article published in PLOS ONE, March 2009
Altmetric Badge

Mentioned by

blogs
2 blogs
twitter
3 X users
facebook
1 Facebook page

Readers on

mendeley
57 Mendeley
citeulike
1 CiteULike
connotea
1 Connotea
Title
Obesity, the Endocannabinoid System, and Bias Arising from Pharmaceutical Sponsorship
Published in
PLOS ONE, March 2009
DOI 10.1371/journal.pone.0005092
Pubmed ID
Authors

John M. McPartland

Abstract

Previous research has shown that academic physicians conflicted by funding from the pharmaceutical industry have corrupted evidence based medicine and helped enlarge the market for drugs. Physicians made pharmaceutical-friendly statements, engaged in disease mongering, and signed biased review articles ghost-authored by corporate employees. This paper tested the hypothesis that bias affects review articles regarding rimonabant, an anti-obesity drug that blocks the central cannabinoid receptor.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 4%
Switzerland 1 2%
New Zealand 1 2%
Spain 1 2%
United States 1 2%
Unknown 51 89%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 18%
Researcher 9 16%
Student > Bachelor 8 14%
Other 5 9%
Professor 4 7%
Other 12 21%
Unknown 9 16%
Readers by discipline Count As %
Medicine and Dentistry 22 39%
Social Sciences 4 7%
Agricultural and Biological Sciences 3 5%
Nursing and Health Professions 3 5%
Neuroscience 2 4%
Other 11 19%
Unknown 12 21%